Kurinami, Noboru
Ashida, Kenji
Sugiyama, Seigo
Morito, Yoko
Yoshida, Akira
Hieshima, Kunio
Miyamoto, Fumio
Kajiwara, Keizo
Jinnouchi, Katsunori
Jinnouchi, Hideaki
Nomura, Masatoshi
Article History
Received: 11 January 2024
Accepted: 18 May 2024
First Online: 28 May 2024
Declarations
:
: HJ has received honoraria from Novo Nordisk, Sanofi, AstraZeneca Pharmaceuticals, Astellas Pharma, Boehringer Ingelheim, Daiichi-Sankyo, Eli Lilly, Takeda, and Novartis Pharmaceuticals. SS has received honoraria from AstraZeneca Pharmaceuticals and Ono Pharmaceutical. The authors declare no other potential conflicts of interest relevant to this study.
: This study was conducted in accordance with the Declaration of Helsinki, and the study protocol was approved by the Human Ethics Review Committee of Jinnouchi Hospital, Kumamoto, Japan (2024-4-1). Informed consent or substitute for it was obtained from all patients for being included in the study.